ADAPT-NK – An Allogeneic Adaptive NK Cell Therapy Platform to Unleash NK Cell Potential
Time: 10:30 am
day: Conference Day One
Details:
- Leveraging adaptive NK cell properties to circumvent inhibitory hurdles of NK cell therapies
- Utilizing highly cytotoxic ADAPT-NK cells against liquid and solid tumor targets, and in combination with engages
- Establishment of manufacturing protocol and cell banks to support dose-escalation and expansion of Phase I/II studies
